{"entity":{"type":"insider","cik":"0001298814","url":"/insider/0001298814","json_url":"/insider/0001298814.json","name":"Fanucci Marsha","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":13,"first":"2006-09-19","last":"2020-06-24","span_basis":"filed_date"},"name_variants":[{"name":"Fanucci Marsha","source":"filing","n_filings":13,"first_seen":"2006-09-19","last_seen":"2020-06-24"}],"transactions":[{"id":3309857,"accession":"0000899243-20-017609","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-20-017609","line_url":"/filing/0000899243-20-017609#line-5","is_derivative":false,"issuer_cik":"0001298814","issuer_name":"Forma Therapeutics Holdings, Inc.,","issuer_ticker":"FMTX","issuer_name_source":null,"issuer_url":"/issuer/0001298814","owner_cik":"0001298814","owner_name":"Fanucci Marsha","owner_display_name":"Fanucci Marsha","owner_url":"/insider/0001298814","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Enterprise 5 Junior Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14026.0,"shares_display":"14,026","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-23","filed_date":"2020-06-24","scope":"insider"},{"id":3309856,"accession":"0000899243-20-017609","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-017609","line_url":"/filing/0000899243-20-017609#line-4","is_derivative":false,"issuer_cik":"0001298814","issuer_name":"Forma Therapeutics Holdings, Inc.,","issuer_ticker":"FMTX","issuer_name_source":null,"issuer_url":"/issuer/0001298814","owner_cik":"0001298814","owner_name":"Fanucci Marsha","owner_display_name":"Fanucci Marsha","owner_url":"/insider/0001298814","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Enterprise 4 Junior Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10240.0,"shares_display":"10,240","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-23","filed_date":"2020-06-24","scope":"insider"},{"id":3309854,"accession":"0000899243-20-017609","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-017609","line_url":"/filing/0000899243-20-017609#line-3","is_derivative":false,"issuer_cik":"0001298814","issuer_name":"Forma Therapeutics Holdings, Inc.,","issuer_ticker":"FMTX","issuer_name_source":null,"issuer_url":"/issuer/0001298814","owner_cik":"0001298814","owner_name":"Fanucci Marsha","owner_display_name":"Fanucci Marsha","owner_url":"/insider/0001298814","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Enterprise 3 Junior Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9847.0,"shares_display":"9,847","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-23","filed_date":"2020-06-24","scope":"insider"},{"id":3309852,"accession":"0000899243-20-017609","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-017609","line_url":"/filing/0000899243-20-017609#line-2","is_derivative":false,"issuer_cik":"0001298814","issuer_name":"Forma Therapeutics Holdings, Inc.,","issuer_ticker":"FMTX","issuer_name_source":null,"issuer_url":"/issuer/0001298814","owner_cik":"0001298814","owner_name":"Fanucci Marsha","owner_display_name":"Fanucci Marsha","owner_url":"/insider/0001298814","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Enterprise 2 Junior Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33781.0,"shares_display":"33,781","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-23","filed_date":"2020-06-24","scope":"insider"},{"id":3309847,"accession":"0000899243-20-017609","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-017609","line_url":"/filing/0000899243-20-017609#line-1","is_derivative":false,"issuer_cik":"0001298814","issuer_name":"Forma Therapeutics Holdings, Inc.,","issuer_ticker":"FMTX","issuer_name_source":null,"issuer_url":"/issuer/0001298814","owner_cik":"0001298814","owner_name":"Fanucci Marsha","owner_display_name":"Fanucci Marsha","owner_url":"/insider/0001298814","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":52532.0,"shares_display":"52,532","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":52532.0,"shares_owned_after_display":"52,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-23","filed_date":"2020-06-24","scope":"insider"},{"id":7987750,"accession":"0001735276-19-000100","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001735276-19-000100","line_url":"/filing/0001735276-19-000100#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001298814","owner_name":"Fanucci Marsha","owner_display_name":"Fanucci Marsha","owner_url":"/insider/0001298814","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":7500000.0,"total_display":"7,500,000.00","total_whole":"7,500,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-20","filed_date":"2019-11-22","scope":"insider"},{"id":8882530,"accession":"0001209191-15-028220","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-028220","line_url":"/filing/0001209191-15-028220#line-1","is_derivative":false,"issuer_cik":"0001298814","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001298814","owner_cik":"0001298814","owner_name":"Fanucci Marsha","owner_display_name":"Fanucci Marsha","owner_url":"/insider/0001298814","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31339.0,"shares_display":"31,339","price_per_share":15.68,"price_display":"15.68","price_state":"stated","total_value":491395.52,"total_display":"491,395.52","total_whole":"491,396","shares_owned_after":19778.0,"shares_owned_after_display":"19,778","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-18","filed_date":"2015-03-20","scope":"insider"},{"id":8108502,"accession":"0001553878-15-000006","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001553878-15-000006","line_url":"/filing/0001553878-15-000006","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001298814","owner_name":"Fanucci Marsha","owner_display_name":"Fanucci Marsha","owner_url":"/insider/0001298814","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":105.79528285,"price_display":"105.80","price_state":"stated","total_value":1057952.8285,"total_display":"1,057,952.83","total_whole":"1,057,953","shares_owned_after":6346.0,"shares_owned_after_display":"6,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-25","filed_date":"2015-02-27","scope":"insider","n_lines":4},{"id":4765056,"accession":"0001179110-13-005280","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-13-005280","line_url":"/filing/0001179110-13-005280#line-1","is_derivative":false,"issuer_cik":"0001235010","issuer_name":"MOMENTA PHARMACEUTICALS INC","issuer_ticker":"MNTA","issuer_name_source":null,"issuer_url":"/issuer/0001235010","owner_cik":"0001298814","owner_name":"Fanucci Marsha","owner_display_name":"Fanucci Marsha","owner_url":"/insider/0001298814","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29400.0,"shares_display":"29,400","price_per_share":14.15,"price_display":"14.15","price_state":"stated","total_value":416010.0,"total_display":"416,010.00","total_whole":"416,010","shares_owned_after":9000.0,"shares_owned_after_display":"9,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-15","filed_date":"2013-03-18","scope":"insider"},{"id":2803582,"accession":"0001325812-12-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001325812-12-000009","line_url":"/filing/0001325812-12-000009#line-1","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001298814","owner_name":"Fanucci Marsha","owner_display_name":"Fanucci Marsha","owner_url":"/insider/0001298814","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":10.75,"price_display":"10.75","price_state":"stated","total_value":107500.0,"total_display":"107,500.00","total_whole":"107,500","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-21","filed_date":"2012-02-23","scope":"insider"},{"id":7133224,"accession":"0001104659-10-004857","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-10-004857","line_url":"/filing/0001104659-10-004857#line-1","is_derivative":false,"issuer_cik":"0001298814","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001298814","owner_cik":"0001298814","owner_name":"Fanucci Marsha","owner_display_name":"Fanucci Marsha","owner_url":"/insider/0001298814","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22000.0,"shares_display":"22,000","price_per_share":11.25,"price_display":"11.25","price_state":"stated","total_value":247500.0,"total_display":"247,500.00","total_whole":"247,500","shares_owned_after":22000.0,"shares_owned_after_display":"22,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-02","filed_date":"2010-02-04","scope":"insider"},{"id":3462997,"accession":"0001298814-08-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001298814-08-000006","line_url":"/filing/0001298814-08-000006#line-2","is_derivative":false,"issuer_cik":"0001002637","issuer_name":"MILLENNIUM PHARMACEUTICALS INC","issuer_ticker":"MLNM","issuer_name_source":null,"issuer_url":"/issuer/0001002637","owner_cik":"0001298814","owner_name":"Fanucci Marsha","owner_display_name":"Fanucci Marsha","owner_url":"/insider/0001298814","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4429.0,"shares_display":"4,429","price_per_share":12.82,"price_display":"12.82","price_state":"stated","total_value":56779.78,"total_display":"56,779.78","total_whole":"56,780","shares_owned_after":112784.0,"shares_owned_after_display":"112,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-11","filed_date":"2008-03-11","scope":"insider"},{"id":3462995,"accession":"0001298814-08-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001298814-08-000006","line_url":"/filing/0001298814-08-000006#line-1","is_derivative":false,"issuer_cik":"0001002637","issuer_name":"MILLENNIUM PHARMACEUTICALS INC","issuer_ticker":"MLNM","issuer_name_source":null,"issuer_url":"/issuer/0001002637","owner_cik":"0001298814","owner_name":"Fanucci Marsha","owner_display_name":"Fanucci Marsha","owner_url":"/insider/0001298814","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5989.0,"shares_display":"5,989","price_per_share":13.3397,"price_display":"13.34","price_state":"stated","total_value":79891.4633,"total_display":"79,891.46","total_whole":"79,891","shares_owned_after":117213.0,"shares_owned_after_display":"117,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-07","filed_date":"2008-03-11","scope":"insider"},{"id":3991396,"accession":"0001298814-08-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001298814-08-000004","line_url":"/filing/0001298814-08-000004#line-1","is_derivative":false,"issuer_cik":"0001002637","issuer_name":"MILLENNIUM PHARMACEUTICALS INC","issuer_ticker":"MLNM","issuer_name_source":null,"issuer_url":"/issuer/0001002637","owner_cik":"0001298814","owner_name":"Fanucci Marsha","owner_display_name":"Fanucci Marsha","owner_url":"/insider/0001298814","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5480.0,"shares_display":"5,480","price_per_share":13.6752,"price_display":"13.68","price_state":"stated","total_value":74940.096,"total_display":"74,940.10","total_whole":"74,940","shares_owned_after":123202.0,"shares_owned_after_display":"123,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider"},{"id":6836647,"accession":"0001298814-07-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001298814-07-000008","line_url":"/filing/0001298814-07-000008#line-2","is_derivative":false,"issuer_cik":"0001002637","issuer_name":"MILLENNIUM PHARMACEUTICALS INC","issuer_ticker":"MLNM","issuer_name_source":null,"issuer_url":"/issuer/0001002637","owner_cik":"0001298814","owner_name":"Fanucci Marsha","owner_display_name":"Fanucci Marsha","owner_url":"/insider/0001298814","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7436.0,"shares_display":"7,436","price_per_share":10.67,"price_display":"10.67","price_state":"stated","total_value":79342.12,"total_display":"79,342.12","total_whole":"79,342","shares_owned_after":75482.0,"shares_owned_after_display":"75,482","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-19","filed_date":"2007-09-19","scope":"insider"},{"id":6836637,"accession":"0001298814-07-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001298814-07-000008","line_url":"/filing/0001298814-07-000008#line-1","is_derivative":false,"issuer_cik":"0001002637","issuer_name":"MILLENNIUM PHARMACEUTICALS INC","issuer_ticker":"MLNM","issuer_name_source":null,"issuer_url":"/issuer/0001002637","owner_cik":"0001298814","owner_name":"Fanucci Marsha","owner_display_name":"Fanucci Marsha","owner_url":"/insider/0001298814","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10064.0,"shares_display":"10,064","price_per_share":10.58,"price_display":"10.58","price_state":"stated","total_value":106477.12,"total_display":"106,477.12","total_whole":"106,477","shares_owned_after":82918.0,"shares_owned_after_display":"82,918","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-18","filed_date":"2007-09-19","scope":"insider"},{"id":7229192,"accession":"0001298814-07-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001298814-07-000006","line_url":"/filing/0001298814-07-000006#line-2","is_derivative":false,"issuer_cik":"0001002637","issuer_name":"MILLENNIUM PHARMACEUTICALS INC","issuer_ticker":"MLNM","issuer_name_source":null,"issuer_url":"/issuer/0001002637","owner_cik":"0001298814","owner_name":"Fanucci Marsha","owner_display_name":"Fanucci Marsha","owner_url":"/insider/0001298814","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4245.0,"shares_display":"4,245","price_per_share":10.64,"price_display":"10.64","price_state":"stated","total_value":45166.8,"total_display":"45,166.80","total_whole":"45,167","shares_owned_after":92982.0,"shares_owned_after_display":"92,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-03-12","filed_date":"2007-03-12","scope":"insider"},{"id":7229189,"accession":"0001298814-07-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001298814-07-000006","line_url":"/filing/0001298814-07-000006#line-1","is_derivative":false,"issuer_cik":"0001002637","issuer_name":"MILLENNIUM PHARMACEUTICALS INC","issuer_ticker":"MLNM","issuer_name_source":null,"issuer_url":"/issuer/0001002637","owner_cik":"0001298814","owner_name":"Fanucci Marsha","owner_display_name":"Fanucci Marsha","owner_url":"/insider/0001298814","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6173.0,"shares_display":"6,173","price_per_share":10.41,"price_display":"10.41","price_state":"stated","total_value":64260.93,"total_display":"64,260.93","total_whole":"64,261","shares_owned_after":97227.0,"shares_owned_after_display":"97,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-03-08","filed_date":"2007-03-12","scope":"insider"},{"id":7317488,"accession":"0001298814-07-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001298814-07-000002","line_url":"/filing/0001298814-07-000002#line-1","is_derivative":false,"issuer_cik":"0001002637","issuer_name":"MILLENNIUM PHARMACEUTICALS INC","issuer_ticker":"MLNM","issuer_name_source":null,"issuer_url":"/issuer/0001002637","owner_cik":"0001298814","owner_name":"Fanucci Marsha","owner_display_name":"Fanucci Marsha","owner_url":"/insider/0001298814","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7497.0,"shares_display":"7,497","price_per_share":11.17,"price_display":"11.17","price_state":"stated","total_value":83741.49,"total_display":"83,741.49","total_whole":"83,741","shares_owned_after":59170.0,"shares_owned_after_display":"59,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-06","filed_date":"2007-02-07","scope":"insider"},{"id":3789838,"accession":"0001298814-06-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001298814-06-000006","line_url":"/filing/0001298814-06-000006#line-1","is_derivative":false,"issuer_cik":"0001002637","issuer_name":"MILLENNIUM PHARMACEUTICALS INC","issuer_ticker":"MLNM","issuer_name_source":null,"issuer_url":"/issuer/0001002637","owner_cik":"0001298814","owner_name":"Fanucci Marsha","owner_display_name":"Fanucci Marsha","owner_url":"/insider/0001298814","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10003.0,"shares_display":"10,003","price_per_share":10.95,"price_display":"10.95","price_state":"stated","total_value":109532.85,"total_display":"109,532.85","total_whole":"109,533","shares_owned_after":66667.0,"shares_owned_after_display":"66,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-09-18","filed_date":"2006-09-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001538927","name":"Forma Therapeutics Holdings, Inc.,","url":"/issuer/0001538927","role":"Director","n_filings":1,"first_seen":"2020-06-24","last_seen":"2020-06-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001178670","name":"ALNYLAM PHARMACEUTICALS, INC.","url":"/issuer/0001178670","role":"Director","n_filings":3,"first_seen":"2012-02-23","last_seen":"2019-11-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001446847","name":"IRONWOOD PHARMACEUTICALS INC","url":"/issuer/0001446847","role":"Director","n_filings":2,"first_seen":"2010-02-04","last_seen":"2015-03-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001235010","name":"MOMENTA PHARMACEUTICALS INC","url":"/issuer/0001235010","role":"Director","n_filings":1,"first_seen":"2013-03-18","last_seen":"2013-03-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001002637","name":"MILLENNIUM PHARMACEUTICALS INC","url":"/issuer/0001002637","role":"Officer (SVP, Chief Financial Officer)","n_filings":6,"first_seen":"2006-09-19","last_seen":"2008-03-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001298814","retrieved_at":"2026-08-27T12:07:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}